Asset Management and Custody Banks

Bayview Acquisition

Bayview Acquisition released FY2025 Q4 earnings on March 13 (EST), actual revenue USD 0, actual EPS USD -0.0112

Bayview Acquisition released FY2025 Annual Earnings on March 13 Post-Market (EST), actual revenue USD 0, actual EPS USD 0.0465

Bayview Acquisition released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.0051

Bayview Acquisition released FY2025 9 Months Earnings on November 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD 0.0432

Bayview Acquisition released FY2025 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 0 and EPS of USD 0.0484

Bayview Acquisition released FY2025 Q2 earnings on August 14 (EST) with actual revenue of USD 0 and EPS of USD 0.0219

Bayview Acquisition Corp. extends business combination deadline

Bayview Acquisition released FY2025 Q1 earnings on May 21 (EST) with actual revenue of USD 0 and EPS of USD 0.0264

Bayview Acquisition Corp. Revises Merger Agreement with Oabay

Bayview Acquisition released FY2024 annual earnings on April 1, 2025 (EST), with actual revenue USD 0 and actual EPS USD 0.2445

Bayview Acquisition released FY2024 Q4 earnings on April 1, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.0033

Bayview Acquisition released FY2024 cumulative 3Q earnings on November 14 (EST), with actual revenue of 0 and EPS of 0.2286

Bayview Acquisition released FY2024 Q3 earnings on November 14 (EST) with actual revenue of 0 USD and EPS of 0.0757 USD

Bayview Acquisition released FY2023 Q3 earnings on November 14, 2024 (EST) with actual revenue of 0 USD and EPS of -0.0025 USD

Bayview Acquisition released FY2023 Cumulative Q3 Earnings on November 14, 2024 (EST), with Revenue 0 and EPS -0.0046

Bayview Acquisition Corp - Oabay Inc. merger is expected to be completed in the second half of 2024

Bayview Acquisition released FY2023 Annual Earnings on April 16, 2024 (EST) with actual revenue USD 0 and actual EPS USD 0

Bayview Acquisition released FY2023 Q4 earnings on April 16 (EST), with actual revenue of USD 0 and EPS of USD 0.0469

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

BAYA

BAYAU

Bayview Acquisition Corp reported a net loss of $(367.3K) and diluted EPS of $(0.23) for Q1 2026, with no operating revenue as it seeks a business combination. The company has approximately $60.0M in trust for this purpose and expects higher public-company expenses post-IPO. Trust proceeds are invested in short-term U.S. government securities to cover tax obligations.

TradingView

Bayview Acquisition - Unit

Bayview Acquisition Corp 1Q 2026: Net income $(367.3K), Diluted EPS $(0.23) — 10-Q Summary

Bayview Acquisition reported a Q1 net loss of $367,344 for the quarter ending March 31, 2026, compared to a net income of $143,915 a year prior. Interest income from marketable securities and bank interest dropped to $104,169, while formation and operating costs increased to $471,513. As of March 31, 2026, cash and cash equivalents stood at $50,187, allocated for identifying and evaluating a target for an initial business combination.

PUBT

Bayview Acquisition Q1 net loss widens to $367,344

Earnings Watch

Bayview Acquisition | 10-Q: FY2026 Q1 Revenue: USD 0

BAYAR

Bayview Acquisition Corp has announced the transfer of its securities from the Nasdaq Global Market to the Nasdaq Capital Market, effective April 24, 2026, following a decision by a Nasdaq Hearings Panel. The company must complete its business combination with Oabay by June 19, 2026, and adhere to initial listing rules. Trading will continue under the symbols BAYA, BAYAU, and BAYAR.

BAYVIEW ACQUISITION CORPORATION COM USD0.0001 (S/R) 17/11/2028

Bayview Acquisition Announced Transfer or Voluntary Withdrawal of Listing

Bayview Acquisition Corp Announces Favorable Nasdaq Listing Decision | BAYA Stock News

StockTitan

Bayview Acquisition Corp Announces Favorable Nasdaq Listing Decision | BAYA Stock News

Bayview Acquisition Faces Nasdaq Delisting Risk, Seeks Relief

Tip Ranks

Bayview Acquisition Faces Nasdaq Delisting Risk, Seeks Relief

Bayview Acquisition reported a net income of $1.753 million for 2024, primarily from interest on cash and trust investments, compared to $0.203 million in the previous year. The company, functioning as a blank-check acquisition vehicle, has no operating revenues, with trust interest income offsetting public-company costs. It completed an IPO raising $62.325 million, with funds placed in trust for future acquisitions. The filing did not present net income per share figures, and the company is incurring costs related to potential acquisition targets.

Bayview Acquisition 10-K: Net income $1.753M in 2024, trust interest funds operating costs

Bayview Acquisition | 10-K: FY2025 Revenue: USD 0

Bayview Acquisition(BAYA.US)

Bayview Acquisition Corp 1Q 2026: Net income $(367.3K), Diluted EPS $(0.23) — 10-Q Summary

Bayview Acquisition Q1 net loss widens to $367,344

Bayview Acquisition | 10-Q: FY2026 Q1 Revenue: USD 0

Bayview Acquisition Announced Transfer or Voluntary Withdrawal of Listing

Bayview Acquisition Corp Announces Favorable Nasdaq Listing Decision | BAYA Stock News

Bayview Acquisition Faces Nasdaq Delisting Risk, Seeks Relief

Bayview Acquisition 10-K: Net income $1.753M in 2024, trust interest funds operating costs

Bayview Acquisition | 10-K: FY2025 Revenue: USD 0